THSD7A provides instructions for a surface protein in certain cells, including kidney and blood vessel lining cells. This gene plays an important role in how cells attach to nearby tissue. If THSD7A is targeted by the immune system or doesn’t work as it should, kidney filters can become leaky. In some people, anti-THSD7A antibodies are linked to membranous nephropathy, leading to protein in the urine and swelling. Most THSD7A-related problems reflect immune mis-targeting, not inherited gene variants.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make certain molecules or to manage activities in the body. Some genes provide the directions for building proteins, which act as the cell’s working components. Other genes mostly guide when specific processes happen, where they occur, and how active they are. Taken together, genes help shape how your body grows and works, and they can affect how you react to things like food, stress, or medicines. More detail on this topic is available in the LearnHub.
Overview
THSD7AGene function
What if the gene works
THSD7A helps certain cells, including blood vessel lining cells and kidney filtering cells, attach and organize their outer surface. Its protein supports cell-to-cell signaling and normal tissue structure, which can aid blood vessel growth and the kidney’s filtration barrier.
Risk
What if the gene does not work
Changes affecting THSD7A in filtering cells can be linked to membranous nephropathy, where protein leaks into urine and swelling can occur. DNA changes can range from mild to severe, influencing age of onset and how much kidney function is affected.
Treatment
What does that mean for your treatment
Treatment often uses immunosuppressants such as rituximab to reduce kidney inflammation. THSD7A antibody levels can help monitor response and decide whether to continue therapy, but inherited changes in the THSD7A gene do not currently guide drug choice or dosing.
Gene function
What if the gene works
Many everyday body functions rely on cells attaching to their surroundings and responding to signals from nearby tissues. Across many tissues, the THSD7A gene contributes to steady, routine cell activity that helps cells keep their structure and connections. It is especially active in cells that line blood vessels and in certain kidney cells that need stable, well-organized surfaces.
The THSD7A gene provides instructions for a cell-surface protein that helps cells connect to the supporting scaffold around them (extracellular matrix). This supports cell shape and stable contact with neighboring structures.
This gene supports how cells arrange themselves as tissues grow and renew. It helps cells respond to outside cues so they can position and align in a coordinated way.
The THSD7A gene function in blood vessel lining cells includes helping them take part in angiogenesis (the normal process of making new blood vessels). This supports healthy tissue oxygen and nutrient delivery during growth and repair.
What is a variant?
A genetic variant is a minor difference in the DNA code within a gene. These differences are widespread and help explain normal variation among people, such as how someone looks, how their body processes energy, or how they react to factors in the environment. Many variants do not cause any obvious change and are part of typical genetic diversity. In certain situations, though, a variant can affect how a gene works in a more meaningful way and may play a role in, or directly lead to, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the THSD7A gene can alter the amount or shape of the THSD7A protein made in certain tissues, including the kidney’s filtering cells. Some THSD7A gene variants are relatively mild and may only slightly shift how the protein sits on the cell surface, while more disruptive mutations can greatly reduce or change the protein and may be linked to earlier or more noticeable kidney-related findings. In some settings, a THSD7A gene mutation in membranous nephropathy is discussed because changes that affect this protein can influence how the immune system recognizes kidney tissue.
How variants are linked to conditions
Changes in the THSD7A gene are not a common inherited explanation for kidney disease, but THSD7A is strongly tied to a subtype of primary membranous nephropathy defined by anti-THSD7A antibodies on clinical testing. In THSD7A-associated membranous nephropathy, studies also show a higher chance of an underlying cancer in some people, so clinicians often consider age-appropriate cancer screening. For most people, common THSD7A variants influence risk at most and do not diagnose the condition.
A variant is not necessarily a diagnosis
Differences in DNA are a typical feature of human biology and are widespread across the general population. Many of these variants do not directly affect health and instead reflect natural variation among people. With many genes, a variant that has been connected to a condition points to a potential association rather than a certain diagnosis, particularly when several genes and environmental influences contribute. In other situations, though, one well-studied variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For THSD7A-related membranous kidney disease, risk is mostly shaped by immune system activity rather than everyday habits, and there is not enough evidence to say diet or supplements lower the chance of developing it. Some cases are linked with certain cancers, especially in older adults, so keeping up with age-appropriate cancer screening can be important. Certain medicines or infections may trigger or worsen kidney inflammation in some people.
Inheritance of THSD7A variants
Changes in the THSD7A gene are usually inherited in an autosomal way, meaning you inherit one copy from each parent and a variant can be passed on by either parent to children of any sex. This describes how THSD7A gene variants are inherited in families when a variant is present. A variant can also arise for the first time in you (de novo) rather than being inherited.
What does my THSD7A result mean for my family?
If you or a close relative has a THSD7A-related kidney condition, new or worsening swelling in the legs or around the eyes, very foamy urine, or sudden weight gain over a few days (about 1–2 kg or 2–5 lb) should prompt medical advice. THSD7A results can affect family discussions and may change how doctors monitor kidney function and choose treatments. Get help right away for shortness of breath, chest pain, or fainting.
Genetic information
Genetic testing
How you find out about variants
To learn whether you carry a change in the THSD7A gene, a lab can analyze DNA from a blood sample or saliva. THSD7A genetic testing for variants typically uses sequencing to read the gene’s code and may also look for missing or extra pieces of DNA. Results report variants found and whether they are likely related to disease.
When should I consider getting a genetic test?
Consider genetic testing for the THSD7A gene when you or a relative has unexplained kidney disease with lots of protein in the urine (often with swelling), especially at a young age. It’s often ordered as part of a kidney-disease gene panel to check for inherited causes. Results can support family risk conversations and next steps in care.
A genetic result is only one part of your health story
A genetic test result can be very informative, but what it can explain varies based on the condition and the kind of variant found. How your body functions over the years is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic details offer helpful context rather than a definite prediction and make the most sense when considered with other parts of care. In other situations, a genetic finding can give a straightforward answer. In areas like medication response, genetic information can help put a person’s individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how people respond to medicines, and this can affect how well a treatment works or how likely side effects are. At this time, changes in the THSD7A gene are not widely used to guide medication choice or predict medication response in routine care. Even so, it is common for two people taking the same drug at the same dose to have different results because their bodies absorb, break down, transport, or react to medicines differently based in part on their genes. Genetics is one piece of the picture, alongside age, other health conditions, kidney and liver function, and other medications.
What is Pharmacogenetics?
Pharmacogenetics focuses on how a person’s genetic differences can affect the way they respond to medicines. It examines relationships between genes and specific drugs to help explain why the same treatment may have different effects in different people. For many medications, genetics can influence how powerfully a drug works or how the body breaks it down. Understanding this can support more informed, more individualized treatment decisions. More information on this topic is available in the LearnHub.
Drugs influenced by the THSD7A gene
When should I seek medical advice?
Seek medical advice if you develop swelling in your legs or around your eyes, foamy urine, unexplained weight gain, or higher blood pressure, which can be signs of kidney protein loss sometimes linked to THSD7A-related kidney disease. Get help sooner if symptoms come on quickly. If you have kidney disease, discuss THSD7A antibody results with a clinician before changing medicines.
History
THSD7A entered the kidney disease conversation after researchers identified it as a target of the immune system in a subset of people with membranous nephropathy, a major step that helped explain why the condition can look similar in different patients but have different underlying triggers. In recent decades, awareness of this gene’s role has grown. By the mid-2010s, laboratory tests began to include THSD7A antibody checks alongside other markers, making it easier to sort membranous nephropathy into more specific categories. As results accumulated, clinicians recognized that THSD7A-positive cases often had distinct patterns compared with other forms of the disease. This shift helped move care toward more personalized evaluation, with follow-up strategies increasingly guided by immune marker status rather than biopsy findings alone.